Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -320 | -41 | -53 | -59 | N/A |
| Depreciation Amortization | 440 | 0 | 0 | N/A | N/A |
| Accounts receivable | -651 | N/A | N/A | N/A | N/A |
| Other Working Capital | -881 | 14 | 17 | 23 | N/A |
| Other Operating Activity | 1,150 | 2 | 2 | 2 | 0 |
| Operating Cash Flow | $-261 | $-25 | $-34 | $-34 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -358 | -5 | -1 | -4 | N/A |
| Other Investing Activity | 0 | -1 | -1 | -1 | 0 |
| Investing Cash Flow | $-358 | $-6 | $-2 | $-5 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -92 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | N/A | 133 | N/A |
| Other Financing Activity | 375 | 0 | 0 | -30 | 0 |
| Financing Cash Flow | $283 | $N/A | $N/A | $103 | $N/A |
| Beginning Cash Position | 587 | 75 | 110 | 46 | N/A |
| End Cash Position | 252 | 43 | 75 | 110 | N/A |
| Net Cash Flow | $-336 | $-32 | $-35 | $64 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -261 | -25 | -34 | -34 | N/A |
| Capital Expenditure | -358 | -5 | -1 | -4 | N/A |
| Free Cash Flow | -619 | -30 | -35 | -38 | 0 |